Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
QuintilesIMS
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Moodys
Chinese Patent Office
Baxter

Generated: June 21, 2018

DrugPatentWatch Database Preview

ZYFLO CR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Zyflo Cr patents expire, and when can generic versions of Zyflo Cr launch?

Zyflo Cr is a drug marketed by Chiesi Usa Inc and is included in one NDA.

The generic ingredient in ZYFLO CR is zileuton. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zileuton profile page.
Drug patent expirations by year for ZYFLO CR
Pharmacology for ZYFLO CR
Synonyms for ZYFLO CR
()-1(1-Benzo[b]thien-2-ylethyl)-1-hydroxyure
(+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea
(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
(+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
(+/-)-N-hydroxy-N-(1-benzo[b]thien-2-ylethyl)urea
1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea
1-(1-benzothiophen-2-ylethyl)-1-hydroxy-urea
1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea
1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea
111406-87-2
133305-01-8
154003-29-9
406Z872
A 64077
A-64077
AB0012645
AB00639921_10
AB00639921_11
AB00639921-06
AB00639921-08
AB00639921-09
AB2000112
Abbot 64077
Abbott 64077
Abbott brand of zileuton
ABBOTT-64077
ABT-077
AC-13198
AC1L1TCB
ACM1189878769
ACMC-1C7JU
ACMC-20n1mn
ACMC-20n2ac
AK-54597
AKOS000280127
AKOS016340558
AN-33562
ANW-61226
API0004645
AX8157141
BB 0261152
BB_NC-02714
BBL029070
BC205769
BDBM50000541
Bio-0924
BS0262
C-14011
C11H12N2O2S
CAS-111406-87-2
CC-35698
CCG-100901
CCG-213571
CHEBI:10112
CHEMBL93
CPD000466377
CS-1563
CTI-02
CTK4B8213
D00414
D09JUG
DB00744
DR000543
DSSTox_CID_3752
DSSTox_GSID_23752
DSSTox_RID_77185
DTXSID9023752
FT-0082368
FT-0601582
GTPL5297
HE295725
HE300396
HMS2051M20
HMS2089J12
HMS2093H06
HMS2235O04
HMS3369I17
HMS3393M20
HMS3654J08
HY-14164
J-002574
J-525169
J90033
K-0925
KS-1195
Leutrol
LS-158908
MCULE-7670046922
MFCD00866097
MLS000759510
MLS001424079
MLS006011971
MolPort-003-850-877
MRF-0000030
MWLSOWXNZPKENC-UHFFFAOYSA-N
N-?(1-?BENZO[B]THIEN-?2-?YLETHYL)-?N-?HYDROXY-?UREA
N-(1-BENZO -N-HYDROXYUREA
N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea
N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-urea
n-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea
N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea
NC00151
NCGC00159453-02
NCGC00159453-03
NCGC00159453-04
NCGC00159453-05
NCGC00159453-06
NCGC00255046-01
NSC-730712
NSC-759277
NSC730712
NSC759277
Pharmakon1600-01505906
Prestwick0_001090
PubChem14804
RL00465
RTC-070927
s1443
SAM001246738
SBI-0206869.P001
SC-15991
SCHEMBL18251470
SCHEMBL4209
SMR000466377
ST24036965
STL373010
TC-070927
Tox21_111680
Tox21_111680_1
Tox21_301148
Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-
Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-, (+-)-
Urea, N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-
Urea,N-(1-benzo[b]thien-2-ylethyl)-N'-hydroxy-
Z1551429725
ZILEUTON
Zileuton (USP/INN)
Zileuton [USAN:INN:BAN]
Zileuton [USAN:USP:INN:BAN]
Zileuton, >=98% (HPLC)
Zileuton, commercially available as 600 mg tablets
Zileuton, United States Pharmacopeia (USP) Reference Standard
Zileutonum
Zileutonum [INN-Latin]
Ziluton
Zyflo
Zyflo (TN)
Zyflo Filmtab
ZYFLO, Zileuton

US Patents and Regulatory Information for ZYFLO CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ZYFLO CR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Cipla
Federal Trade Commission
Accenture
Mallinckrodt
Dow
Healthtrust
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.